hsa-mir-3202 _LIHC.png
TOB2 _LIHC.png
Expression analysis of TCGA samples
Basic Information
VIS ID
TVIS10018462
Fusion event
HBV-TOB2 integration
Validated
No
Detection method
VirusFinder
Data source
Curated
Sample type
Disease
Hepatocellular carcinoma (HCC)
Quality evaluation
Normal
Reported year
2017
PubMed ID
Virus Sequence
Virus name
HBV
Reference genome
Start
1706
Integrated sequence
CGCATGGAGACCACCGTGAACGCCCACCAAATATTGCCCAAGGTCTTACATAAGAGGACTCTTGGACTCTCAGCAATGTCAACGACCGACCTTGAGGCAT| |ACTTCAAAGACTGTTTGTTTAAAGACTGGGAGGAGTTGGGGGAGGAGATTAGGTTAAAGGTCTTTGTACTAGGAGGCTGTAGGCATAAATTGGTCTGCGC
Host Sequence
Chromosome
chr22
Cytoband
q13.2
Reference genome
End
41840051/41444047 (Hg38)
Location type
Intron1
Fragile sites / regions
Target gene
miRNAs that regulate target gene
hsa-mir-378a-3p ; hsa-mir-302a-3p ; hsa-mir-122-5p ; hsa-mir-877-5p ; hsa-mir-744-5p ; hsa-mir-106b-3p ; hsa-mir-320a ; hsa-mir-221-3p ; hsa-mir-630 ; hsa-mir-766-5p ; hsa-mir-3173-3p ; hsa-mir-6891-5p ; hsa-mir-4732-5p ; hsa-mir-3611 ; hsa-mir-7106-5p ; hsa-mir-765 ; hsa-mir-6081 ; hsa-mir-3202 ; hsa-mir-574-5p ; hsa-mir-7515 ; hsa-mir-1252-5p ; hsa-mir-6754-5p ; hsa-mir-4441 ; hsa-mir-4270 ; hsa-mir-4756-5p ; hsa-mir-4739 ; hsa-mir-1321 ; hsa-mir-4433b-3p ; hsa-mir-6876-5p ; hsa-mir-4476 ; hsa-mir-6510-5p ; hsa-mir-6838-5p ; hsa-mir-497-5p ; hsa-mir-424-5p ; hsa-mir-195-5p ; hsa-mir-16-5p ; hsa-mir-15b-5p ; hsa-mir-15a-5p ; hsa-mir-7844-5p ; hsa-mir-4777-5p ; hsa-mir-526a ; hsa-mir-523-5p ; hsa-mir-522-5p ; hsa-mir-520c-5p ; hsa-mir-519c-5p ; hsa-mir-519b-5p ; hsa-mir-519a-5p ; hsa-mir-518f-5p ; hsa-mir-518e-5p ; hsa-mir-518d-5p ; hsa-mir-6770-5p ; hsa-mir-1253 ; hsa-mir-548ax ; hsa-mir-548ao-5p ; hsa-mir-8067 ; hsa-mir-5586-3p ; hsa-mir-6508-5p ; hsa-mir-6127 ; hsa-mir-5006-5p ; hsa-mir-6748-5p ; hsa-mir-6742-5p ; hsa-mir-92a-2-5p ; hsa-mir-4483 ; hsa-mir-6766-5p ; hsa-mir-1293 ; hsa-mir-6756-5p ; hsa-mir-6745 ; hsa-mir-363-5p ; hsa-mir-6747-5p ; hsa-mir-608 ; hsa-mir-4651 ; hsa-mir-4664-5p ; hsa-mir-342-5p ; hsa-mir-504-3p ; hsa-mir-4745-5p ; hsa-mir-4755-3p ; hsa-mir-4481 ; hsa-mir-6813-5p ; hsa-mir-6085 ; hsa-mir-3941 ; hsa-mir-362-3p ; hsa-mir-329-3p ; hsa-mir-32-5p ; hsa-mir-92a-3p ; hsa-mir-92b-3p ; hsa-mir-1207-5p ; hsa-mir-125a-3p ; hsa-mir-3934-5p ; hsa-mir-4493 ; hsa-mir-4736 ; hsa-mir-4740-3p ; hsa-mir-4763-3p ; hsa-mir-506-5p ; hsa-mir-6815-5p ; hsa-mir-6865-5p ; hsa-mir-7150 ; hsa-mir-7160-3p ; hsa-mir-764 ; hsa-mir-892c-5p
Nearest miRNA
hsa-mir-1281/Upstream/190997; hsa-let-7a-3/Downstream/456897;
Upstream sequence
TTCTGTTTCAAAGAGGAAAAGGAGGGATAATGGTGATGGAATCCACTGAGCCCCAAACCCAAAAAGATACTCAGACACCTCTAAGCCTTAAATGTGCAAA
Downstream sequence
CTGTCCTACAATGACGGACTACAGGACTCAACTAAGTGTGGAGGGGCCAGCAGGTGTCACAGACCGGGTGGATGCGAGTGCCCTGCCGCTGTCCGGGGAG
Reference
Yoo, S., et al. A pilot systematic genomic comparison of recurrence risks of hepatitis B virus-associated hepatocellular carcinoma with low- and high-degree liver fibrosis. BMC Med ,2017, 15(1): 214.
Curate